RSS   Newsletter   Contact   Advertise with us
Post Online Media

InVivo Therapeutics appoints interim CFO

InVivo TherapeuticsInVivo Therapeutics Holdings announced that it has appointed Melanie Morel-Ferris as interim chief financial officer from January 1, 2016.
Article continues below

Ms. Morel-Ferris has served as the Company’s Controller since May, 2016. She served as the Corporate Controller of Astrodyne TDI, an electrical manufacturing company from July 2014 to May 2016.

Prior to that, Ms. Morel-Ferris served as the Associate Director of Corporate Accounting of ARIAD Pharmaceuticals, from January 2014 to July 2014, and as a Senior Accounting Manager at ARIAD from January 2011 to December 2013.

Ms. Morel-Ferris, who began her career at Deloitte, received a B.A. from Assumption College and is a Certified Public Accountant.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy